| Alive (n = 324, 78.5%) | Dead (n = 89, 21.5%) | OR (95% CI) | p-value |
---|---|---|---|---|
Sex | ||||
 Female | 136 (45.8) | 37 (45.7) | 1.005 (0.613,1.645) | 0.986 |
 Male* | 161 (54.2) | 44 (54.3) | ||
Age | ||||
  < 60 | 209 (70.4) | 52(64.2) | 1.325 (0.789,2.224) | 0.288 |
  > 60* | 88 (29.6) | 29(35.8) | ||
Malignancy type | ||||
 Solid organ tumor* | 131 (44.1) | 36 (44.4) | 1.014 (0.618,1.662) | 0.957 |
 Hematologic malignancy | 166 (55.9) | 45 (55.6) | ||
 ESR | 73.58 (36.10) | 63.77 (36.88) | 1.008 (0.999,1.017) | 0.091 |
 CRP | 82.12 (43.12) | 88.36 (28.62) | 0.996 (0.989,1.004) | 0.332 |
WBC count | ||||
  < 4000/μl* | 169 (57.3) | 49 (60.5) | 1.142 (0.691,1.885) | 0.605 |
  > 4000/μl | 126 (42.7) | 32 (39.5) | ||
Neutropenia | ||||
 Yes (< 1500/μl) | 121 (41.3) | 33 (41.3) | 1.002 (0.606,1.656) | 0.994 |
 No (> 1500/μl) * | 172 (58.7) | 47 (58.8) | ||
Febrile neutropenia | ||||
 No | 212 (71.4) | 60 (74.1) | 0.873 (0.500,1.524) | 0.633 |
 Yes* | 85 (28.6) | 21 (25.9) | ||
Year | ||||
 2015 | 36 (12.1) | 6 (7.4) | 1.773 (0.612,5.132) | 0.291 |
 2016 | 52 (17.5) | 11 (13.6) | 1.397 (0.569,3.427) | 0.466 |
 2017 | 81 (27.3) | 22 (27.2) | 1.088 (0.500,2.368) | 0.832 |
 2018 | 84 (28.3) | 29 (35.8) | 0.856 (0.405,1.810) | 0.684 |
 2019* | 44 (14.8) | 13 (16) |  |  |
Enterobacterales | ||||
 No* | 70 (36.1) | 18 (38.3) | 1.100 (0.570,2.121) | 0.777 |
 Yes | 124 (63.9) | 29 (61.7) |